TSPO and major depressive disorder: Attwells et al. found that elevated prefrontal and anterior cingulate TSPO signal in patients with refractory MDD predicted a reduction in depressive symptoms in patients taking celecoxib (a nonsteroidal anti-inflammatory drug), which indicate that TSPO-PET could predict treatment response [156].